We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
AromaPass is an online coffee subscription service that gives the user a choice of 3 different coffees that are hand selected each month. AromaPass will use a portion of the investment raised to complete their web page.
days to go: Expired investment: £10,288
Positivitea is a range of teas based on the chakras. They are already stocked in over 80 locations throughout the UK and Europe including Urban Outfitters and Fenwick. The use of the proceeds raised will go towards expanding the team and getting Positivitea in more retail outlets and being used by more suppliers.
days to go: Expired investment: £103,640
Bringing an Italian tradition to the UK, the team at Miccone are raising funds to open their first permanent site in London. 22% of British Adults choose Italian food when eating out, so the team are bringing their experience from an Italian Miccone in Pavia to the streets of London.
days to go: Expired investment: £85,920
Staks is a one-stop-shop for supplements. Their pouches contain a whole days combination of supplements in single serving sachets. Staks is ideal for people that are unsure on what supplements to take or simply don't have time to organise a supplement plan.
days to go: Expired investment: £10,460
Delish Restaurants are founded by young, ambitious entrepreneurs. They aim to be an exciting convenience restaurant with nutritionally balanced dishes affordably. Delish are now raising funds to open their first site in Derby. 
days to go: Expired investment: £5,910
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
A grocery delivery service for customers to purchase goods from local stores via an app. Grocemania launched in August 2017 and has signed more than 20 local and independent stores and gained over 350 users. Income is generated from a flat delivery fee of £2.50, as well as a 10% Commission Fee from its partners. The company has generated more than £27,000 in online sales for local stores in the past 3 months.
days to go: Expired investment: £76,557
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph